Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR21.59B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Cipla INR 12.55B 6.4B Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 5.88B 290M Sep/2025
Pacira USD 38.71M 10.65M Dec/2025
Phibro Animal Health USD 30.48M 1.1M Sep/2024
Prestige Brands USD 90.82M 3.99M Dec/2025
Richter Gedeon HUF 75.72B 6.71B Sep/2024
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025